Hong Kong Stocks Update: LEADS BIOLABS-B (09887) Drops Over 7% Further, Kpc Pharmaceuticals Plans to Sell HKD 132 Million Stake, Founder Voluntarily Extends Lock-Up Period
Stock News
Jul 28
LEADS BIOLABS-B (09887) shares tumbled more than 7% in early trading, adding to recent losses. As of the latest check, the stock was down 6.89% to HKD 54.05, with turnover reaching HKD 608 million.
On July 24, Kpc Pharmaceuticals, Inc. announced plans to sell up to 2,443,022 shares of LEADS BIOLABS-B, with an estimated transaction value of approximately HKD 132 million. Notably, this planned sale comes just ahead of the expiration of LEADS BIOLABS-B's lock-up period.
Meanwhile, Dr. Kang Xiaoqiang, a co-founder of LEADS BIOLABS-B, has stated that he will voluntarily extend the lock-up period for all of his directly held H-shares, totaling approximately 7.875 million shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.